Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Overall Study	STARTED	Drug Sensitive: M (400 mg) Pa (100 mg) Z (1500 mg)	60
Overall Study	STARTED	Drug Sensitive: M (400 mg) Pa (200 mg) Z (1500 mg)	62
Overall Study	STARTED	Drug Sensitive: Rifafour	59
Overall Study	STARTED	Multi Drug-Resistant: M (400 mg) Pa (200 mg) Z (1500 mg)	26
Overall Study	COMPLETED	Drug Sensitive: M (400 mg) Pa (100 mg) Z (1500 mg)	42
Overall Study	COMPLETED	Drug Sensitive: M (400 mg) Pa (200 mg) Z (1500 mg)	39
Overall Study	COMPLETED	Drug Sensitive: Rifafour	41
Overall Study	COMPLETED	Multi Drug-Resistant: M (400 mg) Pa (200 mg) Z (1500 mg)	7
Overall Study	NOT COMPLETED	Drug Sensitive: M (400 mg) Pa (100 mg) Z (1500 mg)	18
Overall Study	NOT COMPLETED	Drug Sensitive: M (400 mg) Pa (200 mg) Z (1500 mg)	23
Overall Study	NOT COMPLETED	Drug Sensitive: Rifafour	18
Overall Study	NOT COMPLETED	Multi Drug-Resistant: M (400 mg) Pa (200 mg) Z (1500 mg)	19

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01498419/flow